RTTNews | Dec 21, 2021 08:05AM EST

08:05 Tuesday, December 21, 2021 (RTTNews) - First Patient Dosed In UroGen Pharma'Study Of UGN-102 In Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved